Literature DB >> 3531380

Defective lymphopoiesis in bone marrow of motheaten (me/me) and viable motheaten (mev/mev) mutant mice. I. Analysis of development of prothymocytes, early B lineage cells, and terminal deoxynucleotidyl transferase-positive cells.

D L Greiner, I Goldschneider, K L Komschlies, E S Medlock, F J Bollum, L Schultz.   

Abstract

This study identifies defects in the early stages of lymphopoiesis that may contribute to the abnormalities in the development and/or function of peripheral T and B lymphocytes in mice homozygous for the motheaten (me/me) and viable motheaten (mev/mev) mutations. The results indicate that in me/me and mev/mev mice prothymocytes in bone marrow are present in essentially normal numbers, as determined by intrathymic injection, but apparently lack the ability to home effectively to the thymus, as determined by intravenous transfer; early B lineage cells in bone marrow, identified by the B220 antigen, are markedly depleted, including immature B cells (sIg+), pre-B cells (cIg+, sIg-), and pro-B cells (B220+, cIg-, sIg-); TdT+ bone marrow cells, especially a subset that expresses the B220 B lineage antigen, are markedly depleted by two weeks of age; normal numbers of TdT+ thymocytes are present during the first 3 wk of postnatal life, but rapidly decrease thereafter. The results further indicate that neither the defective thymus homing capacity of prothymocytes nor the deficiency of TdT+ bone marrow cells is due to autoantibodies. The possible relationship of the defective development of lymphoid precursor cells to the premature onset of thymic involution and to the abnormalities of peripheral T and B lymphocytes in me/me and mev/mev mice is discussed; as are the results of in vitro studies (presented in a companion paper), which suggest that a primary defect in the stromal microenvironment of the bone marrow is responsible for the abnormal development of the lymphoid precursor cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3531380      PMCID: PMC2188409          DOI: 10.1084/jem.164.4.1129

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  43 in total

1.  The effect of thymectomy on the lymphoid tissues of the mouse.

Authors:  D METCALF
Journal:  Br J Haematol       Date:  1960-07       Impact factor: 6.998

2.  Is terminal deoxynucleotidyl transferase a somatic mutagen in lymphocytes?

Authors:  D Baltimore
Journal:  Nature       Date:  1974-03-29       Impact factor: 49.962

3.  Development of terminal deoxynucleotidyl transferase activity in embryonic calf thymus gland.

Authors:  L M Chang
Journal:  Biochem Biophys Res Commun       Date:  1971-07-02       Impact factor: 3.575

4.  Early production of intracellular IgM by B-lymphocyte precursors in mouse.

Authors:  M C Raff; M Megson; J J Owen; M D Cooper
Journal:  Nature       Date:  1976-01-22       Impact factor: 49.962

5.  Motheaten, an immunodeficient mutant of the mouse. II. Depressed immune competence and elevated serum immunoglobulins.

Authors:  L D Shultz; M C Green
Journal:  J Immunol       Date:  1976-04       Impact factor: 5.422

6.  Motheaten, an immunodeficient mutant of the mouse. I. Genetics and pathology.

Authors:  M C Green; L D Shultz
Journal:  J Hered       Date:  1975 Sep-Oct       Impact factor: 2.645

7.  Experimental studies on the development of the thymus.

Authors:  M A Moore; J J Owen
Journal:  J Exp Med       Date:  1967-10-01       Impact factor: 14.307

8.  Terminal deoxynucleotidyl transferase is found in prothymocytes.

Authors:  A E Silverstone; H Cantor; G Goldstein; D Baltimore
Journal:  J Exp Med       Date:  1976-08-01       Impact factor: 14.307

9.  Tissue interaction in the development of thymus lymphocytes.

Authors:  J J Owen; M A Ritter
Journal:  J Exp Med       Date:  1969-02-01       Impact factor: 14.307

10.  Hematopoietic thymocyte precursors. I. Assay and kinetics of the appearance of progeny.

Authors:  J L Kadish; R S Basch
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

View more
  11 in total

1.  Murine "viable motheaten" mutation reveals a gene critical to the development of both B and T lymphocytes.

Authors:  C L Sidman; J D Marshall; R D Allen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

2.  Lack of SHPTP1 results in src-family kinase hyperactivation and thymocyte hyperresponsiveness.

Authors:  U Lorenz; K S Ravichandran; S J Burakoff; B G Neel
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

Review 3.  Molecular biological definition of the prothymocyte: problems of commitment and lineage promiscuity.

Authors:  A E Silverstone; M A Yuille
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

4.  Adoptive transfer of viable motheaten humoral autoimmunity in cyclophosphamide-immunodepressed beige recipient mice.

Authors:  L Kuntz; D Velin; F Pflumio; F Loor
Journal:  Immunology       Date:  1990-08       Impact factor: 7.397

Review 5.  Investigations into the regulation and function of the SH2 domain-containing protein-tyrosine phosphatase, SHP-1.

Authors:  Florence W L Tsui; Alberto Martin; John Wang; Hing Wo Tsui
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 6.  SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels.

Authors:  Ulrike Lorenz
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

7.  Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice.

Authors:  M Kozlowski; I Mlinaric-Rascan; G S Feng; R Shen; T Pawson; K A Siminovitch
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

8.  Defective lymphopoiesis in the bone marrow of motheaten (me/me) and viable motheaten (mev/mev) mutant mice. III. Normal mouse bone marrow cells enable mev/mev prothymocytes to generate thymocytes after intravenous transfer.

Authors:  K L Komschlies; D L Greiner; L Shultz; I Goldschneider
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

9.  Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling.

Authors:  G Pani; M Kozlowski; J C Cambier; G B Mills; K A Siminovitch
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

10.  Depletion of RT6.1+ T lymphocytes induces diabetes in resistant biobreeding/Worcester (BB/W) rats.

Authors:  D L Greiner; J P Mordes; E S Handler; M Angelillo; N Nakamura; A A Rossini
Journal:  J Exp Med       Date:  1987-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.